SLNO Latest Headlines

Optimistic Buy Rating for Soleno Therapeutics Amid Anticipated FDA Approval and Strong Financial Position

at www.tipranks.com (Mon, 3-Mar 6:27 AM)

Soleno Therapeutics Reports 2024 Financial Results and Strategic Progress

at www.tipranks.com (Fri, 28-Feb 11:15 PM)

Piper Sandler Reaffirms Their Buy Rating on Soleno Therapeutics (SLNO)

at www.tipranks.com (Fri, 28-Feb 7:01 AM)

Soleno Therapeutics GAAP EPS of -$1.27

at seekingalpha.com (Thu, 27-Feb 5:33 PM)